Faslodex

10

Transcript of Faslodex

Page 1: Faslodex
Page 2: Faslodex
Page 3: Faslodex
Page 4: Faslodex
Page 5: Faslodex
Page 6: Faslodex
Page 7: Faslodex
Page 8: Faslodex
Page 9: Faslodex
Page 10: Faslodex

Reference ID: 4144559 · FASLODEX is indicated for the treatment of: hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

Reference ID: 4144559 · FASLODEX is indicated for the treatment of: hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

Faslodex (Fulvestrant) Trust Formulary Status February 2015 For the use of Healthcare Professionals 690908.011 March 2015.

Faslodex (Fulvestrant) Trust Formulary Status February 2015 For the use of Healthcare Professionals 690908.011 March 2015.

Full-Year and Q4 2016 Results Performance in line with ... · The focus on research and development is designed to yield strong results from the pipeline. H1 2017 Faslodex - breast

Full-Year and Q4 2016 Results Performance in line with ... · The focus on research and development is designed to yield strong results from the pipeline. H1 2017 Faslodex - breast

Fusion Technical Cover Guide 2017 Xelus 20160927_Gap Cover... · 2017-01-20 · following formulary: Alimta, Avastin, Erbitux, Faslodex, Fludara, Gleevec, Herceptin, Mabthera, Mylotarg,

Fusion Technical Cover Guide 2017 Xelus 20160927_Gap Cover... · 2017-01-20 · following formulary: Alimta, Avastin, Erbitux, Faslodex, Fludara, Gleevec, Herceptin, Mabthera, Mylotarg,

With you every step of the way - Turnberry · 2019. 11. 26. · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin Erbitux Sutent Fludara Mabthera TURNBERRY PRODUCTS

With you every step of the way - Turnberry · 2019. 11. 26. · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin Erbitux Sutent Fludara Mabthera TURNBERRY PRODUCTS

Xelus Technical Guide 2016 f · 2015-12-14 · the following formulary: Alimta, Avastin, Erbitux, Faslodex, Fludara, Gleevec, Herceptin, Mabthera, Mylotarg, Nexavar, Sprycel, Sutent,

Xelus Technical Guide 2016 f · 2015-12-14 · the following formulary: Alimta, Avastin, Erbitux, Faslodex, Fludara, Gleevec, Herceptin, Mabthera, Mylotarg, Nexavar, Sprycel, Sutent,

Assessment Report For Faslodex (fulvestrant) Procedure No ... · Procedure No.: EMEA/H/C/000540/II/0018 EMA/688361/2010 Page 2 1. Scientific discussion 1.1. Introduction Fulvestrant

Assessment Report For Faslodex (fulvestrant) Procedure No ... · Procedure No.: EMEA/H/C/000540/II/0018 EMA/688361/2010 Page 2 1. Scientific discussion 1.1. Introduction Fulvestrant

Reference ID: 4180931 - Food and Drug Administration · FASLODEX is an estrogen receptor antagonist indicated for the: • Treatment of hormone receptor (HR)-positive, human epidermal

Reference ID: 4180931 - Food and Drug Administration · FASLODEX is an estrogen receptor antagonist indicated for the: • Treatment of hormone receptor (HR)-positive, human epidermal

FY 2016 Q4 2016 % change $m % change CER Actual CER Actual€¦ · focus on research and development is designed to yield strong results from the pipeline. H1 2017 Faslodex - breast

FY 2016 Q4 2016 % change $m % change CER Actual CER Actual€¦ · focus on research and development is designed to yield strong results from the pipeline. H1 2017 Faslodex - breast

FASLODEX® (fulvestrant) injection, for intramuscular useAdminister the injection according to the local guidelines for performing large volume intramuscular injections. NOTE: Due

FASLODEX® (fulvestrant) injection, for intramuscular useAdminister the injection according to the local guidelines for performing large volume intramuscular injections. NOTE: Due

Assessment report - European Medicines Agency › en › documents › variation-report › ...Assessment report Faslodex International non-proprietary name: fulvestrant Procedure

Assessment report - European Medicines Agency › en › documents › variation-report › ...Assessment report Faslodex International non-proprietary name: fulvestrant Procedure

Produced by the Njarðarson Group at The University of Arizona · 121 Jadenu 122 Chantix 123 Hepatitis 124 Sutent 125 Shingrix 126 Esbriet 127 Abilify Maintena 128 Entresto 129 Faslodex

Produced by the Njarðarson Group at The University of Arizona · 121 Jadenu 122 Chantix 123 Hepatitis 124 Sutent 125 Shingrix 126 Esbriet 127 Abilify Maintena 128 Entresto 129 Faslodex

Fulvestrant (Faslodex ® ) in advanced breast cancer: What the treatment guidelines say… 679113.011 Date of preparation: March 2015.

Fulvestrant (Faslodex ® ) in advanced breast cancer: What the treatment guidelines say… 679113.011 Date of preparation: March 2015.

(FSP no. 36571) TURNBERRY PRODUCT BROCHURE 2017 · 2019. 11. 26. · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin Erbitux Sutent Fludara Mabthera HER 2 +

(FSP no. 36571) TURNBERRY PRODUCT BROCHURE 2017 · 2019. 11. 26. · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin Erbitux Sutent Fludara Mabthera HER 2 +

With you every step of the way Turnberry Brochure 2018... · 2019-03-19 · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin erbitux Sutent Fludara Mabthera

With you every step of the way Turnberry Brochure 2018... · 2019-03-19 · Nexavar Gleevec Sprycel Faslodex VelcadeTarceva Alimta Zevalin Avastin erbitux Sutent Fludara Mabthera

HIGHLIGHTS OF PRESCRIBING INFORMATION These ......When FASLODEX is used in combination with abemaciclib, the recommended dose of abemaciclib is 150 mg orally, twice daily. Abemaciclib

HIGHLIGHTS OF PRESCRIBING INFORMATION These ......When FASLODEX is used in combination with abemaciclib, the recommended dose of abemaciclib is 150 mg orally, twice daily. Abemaciclib